Mitohormesis reprogrammes macrophage metabolism to enforce tolerance

Greg A Timblin1,2, Kevin M Tharp3, Breanna Ford4,5

  • 1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. greg.timblin@ucsf.edu.

Nature Metabolism
|May 25, 2021
PubMed

Insights

Macrophages utilize mitochondrial stress responses, known as mitohormesis, to limit inflammation. This process impairs pro-inflammatory gene transcription, offering a novel anti-inflammatory strategy.

Area of Science:

  • Immunology
  • Cellular Biology
  • Mitochondrial Biology

Background:

  • Macrophages produce mitochondrial reactive oxygen and electrophilic species during Toll-like receptor (TLR)-dependent inflammation.
  • The impact of this mitochondrial stress on macrophage function remains unclear.

Purpose of the Study:

  • To investigate if mitochondrial stress influences macrophage function.
  • To determine the role of mitohormesis in TLR-dependent inflammatory responses and macrophage tolerance.

Main Methods:

  • Induction of mitochondrial stress in macrophages using pharmacological agents and lipopolysaccharide (LPS).
  • Analysis of macrophage responses, including pro-inflammatory gene transcription and mitochondrial metabolism.
  • Investigation of hydroxyoestrogen-induced mitohormesis.

Main Results:

  • Both pharmacological and LPS-driven mitochondrial stress trigger mitohormesis in macrophages.
  • LPS-induced mitohormesis correlates with the transition to an LPS-tolerant state, characterized by impaired pro-inflammatory gene transcription.
  • Hydroxyoestrogen-induced mitohormesis suppresses mitochondrial metabolism and acetyl-CoA production, leading to impaired histone acetylation and pro-inflammatory gene expression, enforcing LPS tolerance.

Conclusions:

  • Mitochondrial reactive oxygen and electrophilic species act as TLR-dependent signaling molecules that induce mitohormesis.
  • Mitohormesis serves as a negative feedback mechanism to restrain inflammation through macrophage tolerance.
  • Pharmacologically inducing mitohormesis offers a potential anti-inflammatory strategy by disrupting the epigenetic support of pro-inflammatory gene transcription.